FI922017A - Immunbestaemningar och monoklonala antikroppar foer protrombinaktiveringspeptider och degradations- produkter av dessa. - Google Patents

Immunbestaemningar och monoklonala antikroppar foer protrombinaktiveringspeptider och degradations- produkter av dessa. Download PDF

Info

Publication number
FI922017A
FI922017A FI922017A FI922017A FI922017A FI 922017 A FI922017 A FI 922017A FI 922017 A FI922017 A FI 922017A FI 922017 A FI922017 A FI 922017A FI 922017 A FI922017 A FI 922017A
Authority
FI
Finland
Prior art keywords
och
protrombinaktiveringspeptider
monoclonala
immunbestaemningar
antikroppar
Prior art date
Application number
FI922017A
Other languages
English (en)
Other versions
FI109204B (fi
FI922017A0 (fi
Inventor
Bryan Timothy Butman
Jerald Paul Steiner
Bryant Mckoy Moore
Frederick Anthony Dombrose
Marcie Jones Hursting
Original Assignee
Akzo Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23714193&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI922017(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Akzo Nv filed Critical Akzo Nv
Publication of FI922017A0 publication Critical patent/FI922017A0/fi
Publication of FI922017A publication Critical patent/FI922017A/fi
Application granted granted Critical
Publication of FI109204B publication Critical patent/FI109204B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6429—Thrombin (3.4.21.5)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21005—Thrombin (3.4.21.5)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/974—Thrombin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Urology & Nephrology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Exhaust Gas After Treatment (AREA)
  • Transceivers (AREA)
  • Mobile Radio Communication Systems (AREA)
FI922017A 1989-11-06 1992-05-05 Immuunimäärityksiä ja monoklonaalisia vasta-aineita protrombiiniaktivaatiopeptideille ja niiden hajoamistuotteille FI109204B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US43196489A 1989-11-06 1989-11-06
US43196489 1989-11-06
US9006501 1990-11-02
PCT/US1990/006501 WO1991006861A1 (en) 1989-11-06 1990-11-02 Immunoassays for and monoclonal antibodies to prothrombin activation peptides and their degradation products

Publications (3)

Publication Number Publication Date
FI922017A0 FI922017A0 (fi) 1992-05-05
FI922017A true FI922017A (fi) 1992-05-05
FI109204B FI109204B (fi) 2002-06-14

Family

ID=23714193

Family Applications (1)

Application Number Title Priority Date Filing Date
FI922017A FI109204B (fi) 1989-11-06 1992-05-05 Immuunimäärityksiä ja monoklonaalisia vasta-aineita protrombiiniaktivaatiopeptideille ja niiden hajoamistuotteille

Country Status (15)

Country Link
US (1) US5830681A (fi)
EP (1) EP0594576B1 (fi)
JP (1) JP2918688B2 (fi)
KR (1) KR100202773B1 (fi)
AT (1) ATE182366T1 (fi)
AU (1) AU655918B2 (fi)
CA (1) CA2071211C (fi)
DE (1) DE69033220T2 (fi)
DK (1) DK0594576T3 (fi)
ES (1) ES2136598T3 (fi)
FI (1) FI109204B (fi)
GR (1) GR3031607T3 (fi)
IE (1) IE903930A1 (fi)
WO (1) WO1991006861A1 (fi)
ZA (1) ZA908778B (fi)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3727610A1 (de) 1987-08-19 1989-03-02 Behringwerke Ag Synthetische peptide, gegen diese gerichtete antikoerper und deren verwendung
US5942443A (en) * 1996-06-28 1999-08-24 Caliper Technologies Corporation High throughput screening assay systems in microscale fluidic devices
CN1173776C (zh) 1996-06-28 2004-11-03 卡钳技术有限公司 在微规模流体性设备里的高通过量的筛选分析系统
AUPP460398A0 (en) * 1998-07-10 1998-08-06 Life Therapeutics Limited Lupus anticoagulant
US20020132370A1 (en) * 2000-02-23 2002-09-19 Lassen Michael Rud Detection of a blood coagulation activity marker in a body fluid sample
US20020098516A1 (en) * 2000-10-03 2002-07-25 Boystown National Research Hospital Immunodiagnostic determination of usher syndrome type IIA
DE10354403A1 (de) 2003-11-20 2005-06-23 Dade Behring Marburg Gmbh Gegen das Prothrombin-Fragment F 1+2 gerichtete Antikörper, ihre Herstellung und Verwendung
DE102004042124B4 (de) * 2004-08-30 2006-07-06 Dade Behring Marburg Gmbh Homogenes Verfahren zur Bestimmung eines Analyten in Gegenwart eines Überschusses von kreuzreagierenden Substanzen
KR100967614B1 (ko) * 2008-03-14 2010-07-05 주식회사 바이오인프라 Ｄｅｓ－Ｒ 프로트롬빈 활성 펩티드 단편 Ｆ２의 혈청 내농도 측정을 통한 암의 진단 및 스크리닝 방법
DE102008049601A1 (de) 2008-09-30 2010-04-01 Siemens Healthcare Diagnostics Products Gmbh Antikörper zur Bestimmung des Prothrombin-Fragments F2/F1+2 in einem homogenen Immunoassay
DE112010002222B4 (de) 2009-06-04 2024-01-25 Leidos Innovations Technology, Inc. (n.d.Ges.d. Staates Delaware) Mehr-Proben-Mikrofluidchip fur DNA-Analyse
AU2011315951B2 (en) 2010-10-15 2015-03-19 Lockheed Martin Corporation Micro fluidic optic design
US9322054B2 (en) 2012-02-22 2016-04-26 Lockheed Martin Corporation Microfluidic cartridge
EP4239338A1 (de) 2022-03-03 2023-09-06 Siemens Healthcare Diagnostics Products GmbH Globaltest zur feststellung des status des blutgerinnungssystems
WO2023208941A1 (en) 2022-04-26 2023-11-02 Essilor International Photochromic optical article having a mirror coating
EP4325224A1 (de) 2022-08-18 2024-02-21 Siemens Healthcare Diagnostics Products GmbH Thrombozytenaktivierungstest zur diagnose einer heparin-induzierten thrombozytopenie

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3727610A1 (de) * 1987-08-19 1989-03-02 Behringwerke Ag Synthetische peptide, gegen diese gerichtete antikoerper und deren verwendung

Also Published As

Publication number Publication date
US5830681A (en) 1998-11-03
DK0594576T3 (da) 2000-02-07
FI109204B (fi) 2002-06-14
DE69033220T2 (de) 2000-01-20
KR100202773B1 (ko) 1999-06-15
IE903930A1 (en) 1991-05-08
EP0594576A4 (en) 1993-03-15
FI922017A0 (fi) 1992-05-05
ZA908778B (en) 1991-10-30
CA2071211A1 (en) 1991-05-07
EP0594576A1 (en) 1994-05-04
ES2136598T3 (es) 1999-12-01
AU6956391A (en) 1991-05-31
JPH05504473A (ja) 1993-07-15
EP0594576B1 (en) 1999-07-21
AU655918B2 (en) 1995-01-19
DE69033220D1 (de) 1999-08-26
JP2918688B2 (ja) 1999-07-12
GR3031607T3 (en) 2000-01-31
WO1991006861A1 (en) 1991-05-16
CA2071211C (en) 2003-02-18
ATE182366T1 (de) 1999-08-15

Similar Documents

Publication Publication Date Title
FI922017A0 (fi) Immunbestaemningar och monoklonala antikroppar foer protrombinaktiveringspeptider och degradations- produkter av dessa.
NO331148B1 (no) Anvendelse av et monoklonalt eller polyklonalt antistoff, samt fremgangsmate og kit for in vitro diagnose.
ATE290212T1 (de) Immunologische bestimmungen von prostata- spezifischem antigen
DK0678122T3 (da) Rekombinante anti-VLA4 antistofmolekyler
ES8206856A1 (es) Mejoras en un metodo y su correspondiente equipo de ensayo para determinar antigenos por medio de una reaccion inmuno- quimica
ATE318147T1 (de) Spezifische monoklonale antikörperfür die extrazelluläre domäne von protasta-spezifischem membranantigen
ATE134448T1 (de) Bestimmung von freiem und komplexiertem prostat- spezifisches antigen
ATE160575T1 (de) Für toxin b von clostridium difficile spezifische monoklonale antikörper
NO964015L (no) Fremgangsmåte for påvisning av kalpain-aktivering og identifisering av kalpain-inhibitorer
DE69132122D1 (de) Reinigung von cytokeratinfragmenten
NO163920C (no) Fremgangsmaate for bestemmelse av pivka-ii i fysiologiske proever.
ES2072423T3 (es) Anticuerpo monoclonal e inmunoensayo para el factor beta xiia de coagulacion de la sangre.
ES8504257A1 (es) Un metodo para determinar antigenos estreptococales en una muestra clinica
YU46858B (sh) Postupak za dobijanje imunoglobulinskih konjugata
ATE280229T1 (de) Enterotoxine von shigella flexneri 2a
ES2061664T3 (es) Anticuerpos monoclonales que reconocen a alfa-hanp y correspondientes hibridomas, su preparacion y uso.
CA2054689A1 (en) An immunoassay method for determining the specificity of binding of a monoclonal antibody to an antigen
DK329789A (da) Monoklonalt antistof
DK176986D0 (da) Monoklonalt anti-urokinase-antistof og produktion og anvendelse deraf
DE69114546D1 (de) Neue Verwendung für einen monoklonalen Antikörper.
SE8705137D0 (sv) Diagnostic method for primary biliary cirrhosis and antibodies suitable to be used in certain versions of the method
JPS6459070A (en) Immunoassay method
CA2178504A1 (en) Immunoassays for prostate specific antigen

Legal Events

Date Code Title Description
MA Patent expired